These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 17191007)
1. Osteoimmunology. Rauner M; Sipos W; Pietschmann P Int Arch Allergy Immunol; 2007; 143(1):31-48. PubMed ID: 17191007 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory bone destruction and osteoimmunology. Takayanagi H J Periodontal Res; 2005 Aug; 40(4):287-93. PubMed ID: 15966905 [TBL] [Abstract][Full Text] [Related]
3. The dynamic interplay between osteoclasts and the immune system. Nakashima T; Takayanagi H Arch Biochem Biophys; 2008 May; 473(2):166-71. PubMed ID: 18410741 [TBL] [Abstract][Full Text] [Related]
4. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Sato K; Takayanagi H Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464 [TBL] [Abstract][Full Text] [Related]
5. Interplay between interferon and other cytokine systems in bone metabolism. Takayanagi H; Sato K; Takaoka A; Taniguchi T Immunol Rev; 2005 Dec; 208():181-93. PubMed ID: 16313349 [TBL] [Abstract][Full Text] [Related]
6. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Takayanagi H Nat Rev Immunol; 2007 Apr; 7(4):292-304. PubMed ID: 17380158 [TBL] [Abstract][Full Text] [Related]
7. New immune connections in osteoclast formation. Takayanagi H Ann N Y Acad Sci; 2010 Mar; 1192():117-23. PubMed ID: 20392226 [TBL] [Abstract][Full Text] [Related]
8. [Bone and calcium update; bone research update. Osteoclastogenesis and osteoimmunology]. Nakashima T; Hayashi M; Takayanagi H Clin Calcium; 2011 Dec; 21(12):93-102. PubMed ID: 22133829 [TBL] [Abstract][Full Text] [Related]
9. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Bar-Shavit Z Autoimmunity; 2008 Apr; 41(3):195-203. PubMed ID: 18365832 [TBL] [Abstract][Full Text] [Related]
10. Biology of the basic multicellular unit and the pathophysiology of osteoporosis. Jilka RL Med Pediatr Oncol; 2003 Sep; 41(3):182-5. PubMed ID: 12868116 [TBL] [Abstract][Full Text] [Related]
14. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process. Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895 [TBL] [Abstract][Full Text] [Related]
15. [Osteoimmunology: an integrated vision of immune and bone systems]. Gallois A; Mazzorana M; Vacher J; Jurdic P Med Sci (Paris); 2009 Mar; 25(3):259-65. PubMed ID: 19361389 [TBL] [Abstract][Full Text] [Related]
17. The role of the immune system in the pathophysiology of osteoporosis. Clowes JA; Riggs BL; Khosla S Immunol Rev; 2005 Dec; 208():207-27. PubMed ID: 16313351 [TBL] [Abstract][Full Text] [Related]
18. Osteoimmunology: the study of the relationship between the immune system and bone tissue. Arboleya L; Castañeda S Reumatol Clin; 2013; 9(5):303-15. PubMed ID: 23727459 [TBL] [Abstract][Full Text] [Related]
19. Key roles of the OPG-RANK-RANKL system in bone oncology. Baud'huin M; Duplomb L; Ruiz Velasco C; Fortun Y; Heymann D; Padrines M Expert Rev Anticancer Ther; 2007 Feb; 7(2):221-32. PubMed ID: 17288531 [TBL] [Abstract][Full Text] [Related]
20. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]